ACTR707
ATTCK-20-03
Phase 1 mab terminated
Quick answer
ACTR707 for Lymphoma is a Phase 1 program (mab) at Cogent Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cogent Biosciences
- Indication
- Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated